Publications by authors named "Margarethe Wacker"

Claim this Profile
R
Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis.
Antje Mevius, Florian Karl, Margarethe Wacker, Robert Welte, Stefanie Krenzer

J Cancer Res Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET.
Danalyn Byng, Johanna I Lutter, Margarethe E Wacker, Rudolf A Jörres, Xiaofei Liu

Int J Chron Obstruct Pulmon Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study.
Johanna I Lutter, Boglárka Szentes, Margarethe E Wacker, Joachim Winter, Sebastian Wichert

Health Econ Rev· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Health Science Research with Primary Care Routine Data From Electronic Patient Records: the BeoNet Registry].
Heidrun Lingner, Ines Aumann, Margarethe Wacker, Michael Kreuter, Reiner Leidl

Gesundheitswesen· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort.
Margarethe E Wacker, Katharina Kitzing, Rudolf A Jörres, Reiner Leidl, Holger Schulz

Int J Chron Obstruct Pulmon Dis· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of generic health-related quality of life (EQ-5D dimensions) and inactivity with lung function in lung-healthy German adults: results from the KORA studies F4L and Age.
Agnes Luzak, Stefan Karrasch, Margarethe Wacker, Barbara Thorand, Dennis Nowak

Qual Life Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The revised GOLD 2017 COPD categorization in relation to comorbidities.
Kathrin Kahnert, Peter Alter, David Young, Tanja Lucke, Joachim Heinrich, Margarethe Wacker

Respir Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
Kathrin Kahnert, Tanja Lucke, Rudolf M Huber, Jürgen Behr, Frank Biertz, Margarethe Wacker

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of Medication.
Tanja Lucke, Ronald Herrera, Margarethe Wacker, Rolf Holle, Frank Biertz

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, Andrew H Briggs, Sixten Borg, Margarethe E Wacker

Value Health· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
Florian M Karl, Rolf Holle, Robert Bals, Timm Greulich, Rudolf A Jörres, Margarethe E Wacker

Respir Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, Andrew H Briggs, Ryan N Hansen, Margarethe Wacker

Value Health· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study.
Sarah Houben-Wilke, Rudolf A Jörres, Robert Bals, Frits M E Franssen, Sven Gläser, Margarethe E Wacker

Am J Respir Crit Care Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.
Kathrin Kahnert, Tanja Lucke, Frank Biertz, Andreas Lechner, Henrik Watz, Margarethe Wacker

Respir Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies.
Susanne Ulrich, Rolf Holle, Margarethe Wacker, Renee Stark, Andrea Icks

BMJ Open· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.
Michael Kreuter, Felix J F Herth, Margarethe Wacker, Reiner Leidl, Andreas Hellmann

Biomed Res Int· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chronic ischemic heart disease on the health care costs of COPD patients - An analysis of German claims data.
Larissa Schwarzkopf, Margarethe Wacker, Julia Ertl, Jana Hapfelmeier, Katharina Larisch

Respir Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.
Margarethe E Wacker, Rudolf A Jörres, Annika Karch, Armin Koch, Joachim Heinrich

Respir Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.
Margarethe E Wacker, Rudolf A Jörres, Annika Karch, Sarah Wilke, Joachim Heinrich

BMC Pulm Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review.
Manuel B Huber, Margarethe E Wacker, Claus F Vogelmeier, Reiner Leidl

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better understanding of the health care costs of lung cancer and the implications.
Reiner Leidl, Margarethe Wacker, Larissa Schwarzkopf

Expert Rev Respir Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review.
Manuel B Huber, Margarethe E Wacker, Claus F Vogelmeier, Reiner Leidl

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens.
Larissa Schwarzkopf, Margarethe Wacker, Rolf Holle, Reiner Leidl, Christian Günster

Lung Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and chronic obstructive pulmonary disease in early stages - longitudinal results from the population-based KORA cohort in a working age population.
Margarethe E Wacker, Matthias Hunger, Stefan Karrasch, Joachim Heinrich, Annette Peters

BMC Pulm Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.
Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, Sixten Borg, Ryan N Hansen, Margarethe Wacker

Value Health· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis